Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Filings indexed 2,231 across all filing types
Latest filing 2024-06-05 Director's Dealing
Country TW Taiwan
Listing TW 1789

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
113年05月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It lists share counts, pledged shares, and related ratios. The content is focused on insider shareholdings and their changes, not on financial results, management changes, or meeting materials. This type of detailed insider shareholding disclosure aligns with the category of Director's Dealing, which reports personal share transactions or holdings by company directors and executives. The document is about insider holdings and pledges, which fits best under Director's Dealing (DIRS). The document length is 5735 characters, which is sufficient for a detailed insider shareholding report, not a brief announcement or certification. Therefore, the classification is DIRS with high confidence.
2024-06-05 Chinese
公告本公司董事會推選羅智先先生續任董事長
Board/Management Information Classification · 100% confidence The document is a company announcement regarding the reappointment of a chairman of the board, including details about the board resolution date, the outgoing and incoming chairman, and the reason for the change. It does not contain financial data, audit information, or report content. It is clearly about a change in senior management (board/management information). Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and focused on management change, not a report or announcement of a report.
2024-05-28 Chinese
公告本公司薪資報酬委員會任期屆滿
Board/Management Information Classification · 95% confidence The document is a company announcement regarding the expiration of the term of the company's Compensation Committee members. It lists the old members, their resumes, and states that new members have not yet been appointed. There is no financial data, no report attached or referenced, and no mention of any financial results or regulatory filings. This is an announcement about board/committee changes, which fits the category of Board/Management Information (MANG). The document length is short and it is a direct announcement of management-related changes, not a report or presentation.
2024-05-28 Chinese
公告本公司審計委員會成員異動
Board/Management Information Classification · 100% confidence The document is a company announcement regarding changes in the members of the Audit Committee, specifying old and new members, their resumes, and the reason for the change (term expiration). It does not contain financial data, audit opinions, or detailed audit results, so it is not an Audit Report (AR). It is not a full Annual Report (10-K) or any financial report. It is clearly an announcement about board/committee member changes, which fits the Board/Management Information (MANG) category.
2024-05-28 Chinese
公告本公司民國113年股東常會通過許可解除董事(含獨立 董事)及其代表人競業禁止之限制
Board/Management Information Classification · 95% confidence The document is a formal announcement from a listed company (神隆) regarding the approval at the shareholders' meeting (股東常會) held on 113/05/28 (Taiwanese calendar year) to permit certain directors and their representatives to engage in competitive business activities, which were previously restricted. It details the names, titles, and business activities of these directors, including those related to mainland China operations. The content is focused on board-related decisions and disclosures about directors' permissions and competitive activities, not financial results or reports. There is no indication of financial statements, earnings data, or audit information. The document is a regulatory announcement about board permissions and restrictions, fitting the category of Board/Management Information (MANG).
2024-05-28 Chinese
公告本公司民國113年股東常會董事任期屆滿改選
Board/Management Information Classification · 95% confidence The document is a formal announcement from a listed company (1789 神隆) regarding the expiration and re-election of the board of directors at the shareholders' meeting held on 113/05/28 (Taiwanese calendar year). It details the old and new directors, their titles, biographies, shareholdings, and the reason for the change (term expiration and full re-election). There is no financial data, earnings, or report content. The document is an announcement of changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is 3249 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is MANG with high confidence.
2024-05-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.